Healthcare IPOs are active tonight with Metsera (MTSR.US) and Maze (MAZE.US) going public.

Two pharmaceutical companies, Metsera (MTSR.US) and Maze Therapeutics (MAZE.US), announced their IPO pricing on Thursday. Metsera priced its IPO at $18 per share (above the previously announced IPO price range of $15-$17), and will sell 15.3 million shares to raise $275 million, according to a statement. Meanwhile, Maze Therapeutics priced its IPO at $16 per share (the midpoint of the previously announced IPO price range), and will sell 8.75 million shares to raise $140 million. The two companies will raise a total of $415 million.